To further investigate the expression change of these genes before and after TMZ treatment, we integrated a total of 40 paired RNA-seq data of initial and matched TMZ-treated recurrent IDH-wt GBM samples [18, 19]. This evidence concerns the gene IDH1 and glioblastoma.